Immune Thrombocytopenia clinical trials at UCSF
1 in progress, 0 open to eligible people
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Sorry, not currently recruiting here
This is an investigator initiated, multicenter, open label, randomized phase 3 study for subjects with newly diagnosed ITP from ages 1 to less than 18 years old.
San Francisco, California and other locations